Explore Investments LLC 13D/13G Filings for Lyell Immunopharma, Inc. (LYEL)

Explore Investments LLC 13D and 13G filings for Lyell Immunopharma, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2025-08-19
4:10 pm
Purchase
2025-07-2513GLYELL IMMUNOPHARMA INC
LYEL
Explore Investments LLC1,040,964
5.400%
1,040,964increase
(New Position)
Filing